(Q38228157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sandro Mazzaferro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

Marinella Ruospo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Roberto Russo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Luca De Nicola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Andrea Icardi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ernesto Paoletti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

11 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

published in

Journal of Nephrology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

483-494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25012237%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40620-014-0120-x

9 March 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Global trends in rates of peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Chronic kidney disease and vitamin D: how much is adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

25-Hydroxyvitamin D levels in prevalent Australian dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Clinical practice. Vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Renoprotective effects of vitamin D analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

The prognostic role of brain natriuretic peptides in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Diversity in peritoneal macrophage response of CAPD patients to 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Vitamin D metabolites and/or analogs: which D for which patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Effectiveness of treatment with oral paricalcitol in patients on peritoneal dialysis: a Spanish multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0120-X

Trends in CAPD technique failure: Canada, 1981-1997.

21 January 2018

1 reference

12 December 2020

Interrelationships between B-type natriuretic peptides and vitamin D in patients on maintenance peritoneal dialysis

1 reference

12 December 2020

Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients

1 reference

12 December 2020

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

1 reference

12 December 2020

Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/L dialysate calcium

1 reference

12 December 2020

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

1 reference

12 December 2020

Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Effect of vitamin D supplementation on calcidiol and parathyroid hormone levels.

1 reference

12 December 2020

Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD

1 reference

12 December 2020

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

1 reference

12 December 2020

Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients

1 reference

12 December 2020

The effect of intraperitoneal 22-oxacalcitriol on secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients (IPOX study).

1 reference

12 December 2020

Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis.

1 reference

12 December 2020

High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism

1 reference

12 December 2020

Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol − a preliminary study

1 reference

12 December 2020

Vitamin D receptors in heart: effects on atrial natriuretic factor

1 reference

12 December 2020

Losses of calcitriol to peritoneal dialysis bags and tubing

1 reference

12 December 2020

Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis

1 reference

12 December 2020

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study

1 reference

12 December 2020

Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients

1 reference

12 December 2020

Oral pulsed calcitriol protocol reduces the prevalence of hyperparathyroidism in a PD unit

1 reference

12 December 2020

Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum--implications for therapeutic targets to prevent encapsulating peritoneal sclerosis

1 reference

12 December 2020

Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients

1 reference

12 December 2020

Secondary hyperparathyroidism in CAPD patients: its suppressibility with high doses of calcitriol

1 reference

12 December 2020

Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations

1 reference

12 December 2020

Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?

1 reference

12 December 2020

Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Intermittent minibolus oral vitamin D3 in CAPD patients with resistant parathyroid hormone values.

1 reference

12 December 2020

Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients

1 reference

12 December 2020

Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients

1 reference

12 December 2020

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study

1 reference

12 December 2020

Effects of calcitriol pulse therapy per os in CAPD patients

1 reference

12 December 2020

Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients

1 reference

12 December 2020

Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome

1 reference

12 December 2020

Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects

1 reference

12 December 2020

Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol

1 reference

12 December 2020

Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial

1 reference

12 December 2020

Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients

1 reference

12 December 2020

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.

1 reference

12 December 2020

Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis

1 reference

12 December 2020

Paricalcitol reduces proteinuria but does not modify peritoneal protein loss in patients on peritoneal dialysis

1 reference

12 December 2020

Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties

1 reference

12 December 2020

Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Effect of calcitriol replacement on serum calcitonin and parathyroid hormone levels in CAPD patients.

1 reference

12 December 2020

Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d

1 reference

12 December 2020

Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol

1 reference

12 December 2020

Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients

1 reference

12 December 2020

Intraperitoneal calcitriol in infants on peritoneal dialysis

1 reference

12 December 2020